Acadia Pharmaceuticals (ACAD) Earnings (2010 - 2026)
Acadia Pharmaceuticals (ACAD) earnings from Jun 30, 2010 to Mar 31, 2026. The TTM Acadia Pharmaceuticals (ACAD) earnings is $376M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Acadia Pharmaceuticals (ACAD) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +64.12% |
| 3 Years TTM | +136.72% |
Annual Earnings change of Acadia Pharmaceuticals (ACAD)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $3.64M | -99.07% |
| 2025 | $391M | +72.67% |
| 2024 | $226M | +394.43% |
| 2023 | $46M | -209.78% |
| 2022 | -$42M | -3.18% |
| 2021 | -$43M | -84.70% |
| 2020 | -$282M | +19.69% |
| 2019 | -$235M | -4.05% |
| 2018 | -$245M | -15.28% |
| 2017 | -$289M | +6.64% |
| 2016 | -$271M | +65.04% |
| 2015 | -$164M | +77.83% |
| 2014 | -$92M | +143.66% |
| 2013 | -$38M | +82.01% |
| 2012 | -$21M | -8.39% |
| 2011 | -$23M | -250.33% |
| 2010 | $15M | -133.54% |
| 2009 | -$45M | N/A |